Literature DB >> 18249166

Selective versus total insulin resistance: a pathogenic paradox.

Michael S Brown1, Joseph L Goldstein.   

Abstract

Mice with type 2 diabetes manifest selective hepatic insulin resistance: insulin fails to suppress gluconeogenesis but continues to activate lipogenesis, producing the deadly combination of hyperglycemia and hypertriglyceridemia. In this issue of Cell Metabolism, Biddinger et al. (2008) show that mice with total hepatic insulin resistance exhibit hyperglycemia without hypertriglyceridemia-a state paradoxically less severe than selective insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18249166     DOI: 10.1016/j.cmet.2007.12.009

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  386 in total

Review 1.  The role of lipid droplets in metabolic disease in rodents and humans.

Authors:  Andrew S Greenberg; Rosalind A Coleman; Fredric B Kraemer; James L McManaman; Martin S Obin; Vishwajeet Puri; Qing-Wu Yan; Hideaki Miyoshi; Douglas G Mashek
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.

Authors:  Kebin Zhang; Ling Li; Yajuan Qi; Xiaoping Zhu; Boyi Gan; Ronald A DePinho; Travis Averitt; Shaodong Guo
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

3.  Retinoids induced Pck1 expression and attenuated insulin-mediated suppression of its expression via activation of retinoic acid receptor in primary rat hepatocytes.

Authors:  Yan Zhang; Rui Li; Wei Chen; Yang Li; Guoxun Chen
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

4.  Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose.

Authors:  Raffaella Crescenzo; Francesca Bianco; Italia Falcone; Paola Coppola; Giovanna Liverini; Susanna Iossa
Journal:  Eur J Nutr       Date:  2012-04-28       Impact factor: 5.614

Review 5.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

6.  mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-18       Impact factor: 11.205

Review 7.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

8.  ChREBP regulates fructose-induced glucose production independently of insulin signaling.

Authors:  Mi-Sung Kim; Sarah A Krawczyk; Ludivine Doridot; Alan J Fowler; Jennifer X Wang; Sunia A Trauger; Hye-Lim Noh; Hee Joon Kang; John K Meissen; Matthew Blatnik; Jason K Kim; Michelle Lai; Mark A Herman
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

9.  Fatty acid metabolism and thyroid hormones.

Authors:  Naomi L Sayre; James D Lechleiter
Journal:  Curr Trends Endocinol       Date:  2012-01-01

10.  Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice.

Authors:  Akihiro Asai; Pauline M Chou; Heng-Fu Bu; Xiao Wang; M Sambasiva Rao; Anthony Jiang; Christine J DiDonato; Xiao-Di Tan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-16       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.